Trametes versicolor na medicina contra o cancro
... research by our center continues to indicate that Trametes versicolor represents a novel immune therapy with significant applications in cancer treatment ... The CD8+ T cell counts over the 9-week dose escalation study were enhanced in the 9 gm Tv dose cohort compared to both the 3 g or 6 g group. One-way ANOVA was used to analyze the overall difference between dosage groups over the treatment period (2-4-6 weeks). It showed the statistically significant increase in the CD8+ cytotoxic T cells for the 9 g group compared to both the 3 g and 6 g group (F(2, 6) = 42.04, P = 0.0003).